Descartes-11

Overview

Descartes-11 is an autologous CD8+ anti-BCMA CAR T cell therapy being developed for patients with multiple myeloma.

SparkCures ID 347
Developed By Cartesian Therapeutics
Generic Name Descartes-11
Treatment Classifications
Treatment Targets

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.